Rabbit anti-cAbl Antibody, Affinity Purified
SIGMA/PLA0204 - Powered by Bethyl Laboratories, Inc.
Synonym: ABL; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; JTK7; bcr/abl; bcr/c-abl oncogene protein; c-ABL; c-ABL1; c-abl oncogene 1; c-abl oncogene 1; non-receptor tyrosine kinase; p150; proto-oncogene c-Abl; proto-oncogene tyrosine-protein kinase ABL1; receptor tyrosine kinase; v-abl; v-abl Abelson murine leukemia viral oncogene homolog 1
Product Type: Product-on-demand
Immunohistochemistry Rabbit Anti-cAbl Antibody, Affinity Purified: Cat. No. PLA0204: Detection of Human cAbl by Immunohistochemistry and Immunocytochemistry. Sample: FFPE section of Human ovarian carcinoma (left) and formaldehyde-fixed K562 cells (contains the chromosomal translocation, t(9:22) that creates the BCR/ABL fusion gene) (right). Antibody: Affinity purified Rabbit Anti-cAbl (Cat. No. PLA0204) used at a dilution of 1:1,000 (1 μg/mL). Detection: DAB staining and Red-fluorescent goat Anti-Rabbit IgG cross-adsorbed Antibody used at a dilution of 1:100.
| accession no. | NP_005148.2 |
| antibody form | affinity purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| conjugate | unconjugated |
| Quality Level | 100  |
| shipped in | wet ice |
| species reactivity | human |
| storage temp. | 2-8°C |
| target post-translational modification | unmodified |
| technique(s) | immunofluorescence: 1:500- 1:2,000 |
| immunohistochemistry: 1:500- 1:2,000 | |
| immunoprecipitation (IP): 2- 5 μg/mg |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| Immunogen: | The epitope recognized by PLA0204 maps to a region between residue 850 and 900 of human v-abl Abelson murine leukemia viral oncogene homolog 1 using the numbering given in entry NP_005148.2 (GeneID 25). |
| Other Notes: | c-Abl is the human cellular homolog of a the v-Abl viral oncogene. v-Abl was originally discovered as a mouse cell-derived sequence in the genome of the Abelson murine leukemia virus (A-MuLV), a transforming retrovirus isolated by the laboratory of Dr. H.T. Abelson. c-Abl is a tyrosine kinase from the Src-family of tyrosine kinases that localizes to both the cytoplasm and nucleus. It bears an SH2 (src-homology 2) and SH3 (src-homology 3) domain responsible for mediating c-Abl protein-protein interactions. c-Abl is implicated to play a role in multiple cellular processes such as cell cycle checkpoint signaling, apoptosis, cell differentiation, cell adhesion, and transcriptional regulation. Chromosomal translocations involving the c-Abl gene are associated with human leukemias. |
| Physical form: | Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide |
| RIDADR | NONH for all modes of transport |
| WGK Germany | nwg |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352203 |